Umay Balcı

Umay Balcı

Auto-generated profile, based on publicly available information

Umay Balcı

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences Turkey, Antalya Training and Research Hospital, Antalya, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2022 in Klimik Dergisi/Klimik Journal
Verified
Journal Article
Open access
ODOnder Demir-Onder
Onder Demir-Onder
ASAysegül Seremet-Keskin
Aysegül Seremet-Keskin
ADAYLIN ERMAN DALOGLU
AYLIN ERMAN DALOGLU
UBUmay Balcı
Umay Balcı
ÜÜÜlkü Üser
Ülkü Üser
UHUmay BalcıAffiliationsSağlık Bilimleri Üniversitesi Antalya Eğitim ve Araştırma Hastanesi
Umay BalcıAffiliationsSağlık Bilimleri Üniversitesi Antalya Eğitim ve Araştırma Hastanesi
Objective: Multiple factors have been studied in association with disease severity in COVID-19. The cycle threshold (Ct) value of polymerase chain reaction (PCR) can reflect viral load in the specimens. In this study, we aimed to evaluate the effect of the Ct value on clinical course and mortality in COVID-19 patients. Methods: Adult patients who tested positive for SARS-CoV-2 with PCR test and who were hospitalized with COVID-19-related symptoms between August 1, 2020, and November 30, 2020, were included in the study. In addition, Ct value, demographic and clinical data (length of hospital stay, need for admission to intensive care unit (ICU), need for mechanical ventilation (MV), and mortality) were reviewed retrospectively. Results: 117 patients were included in the study. The mean Ct value was 22.37±4.72 (11.07-34.06). There was no significant difference in the mean Ct values between the patients who needed ICU admission and those who did not. When the patients were evaluated by dividing them into three groups according to their Ct values, as < 20, between 20-24 and >24; there was no significant difference between these three groups in terms of severity of pneumonia, laboratory parameters (D-dimer, Neutrophil/Lymphocyte ratio, C-reactive protein, lymphocyte count), length of hospital stay, need for ICU admission, need for MV and mortality. When the patients were divided into two groups with Ct values as <23.3 and ≥23.3, no significant difference was found between the groups regarding ICU need, MV need, and 28-day mortality rates. Conclusion: Most of the studies in the literature about Ct value and its effect on clinical course indicate that lower Ct values are potentially associated with worse outcomes in COVID-19. However, there are also studies reporting that the Ct value does not reflect the severity of the disease. We did not find a correlation between Ct value and laboratory markers, length of hospital stay, the severity of pneumonia, need for ICU admission or MV, and mortality in COVID-19 patients in this presented study.

1 July 2024
Verified
Book Chapter
Closed access
SKSibel Nargiz Koşucu
Sibel Nargiz Koşucu
AÇArife Altın Çetin
Arife Altın Çetin
AGAyla Gürsoy
Ayla Gürsoy
UBUmay Balcı
Umay Balcı
Solid organ nakli (SON) yapılan hastalarda, immünosüpresif ilaçlar ve cerrahi tekniklerdeki ilerlemelere rağmen enfeksiyonlar hala ciddi bir sağlık sorunudur. Bağışıklığı baskılanmış SON alıcılarında geniş patojen yelpazesi risk oluşturmakta, enfeksiyonlar morbidite ve mortaliteye yol açmaktadır. SON alıcılarının nakil sonrası komplikasyonlarını azaltmak için hasta, bakım verici ve sağlık ekibi üçgeninde enfeksiyondan korunmaya yönelik önlemlere titizlikle uyulması gerekmektedir. Hemşirenin SON yapılan hastalarda bakım verici rolü yanında; aşılama programlarının yürütülmesi, hastaların evde izlemleri, her aşamada hasta ve yakınlarının eğitimi ve danışmanlık girişimlerini de yürütmesi gerekmektedir.

1 July 2024
Verified
Book
Open access
PDF file
AUAdam Uslu
Adam Uslu
FHF. Sevgi Hatipoğlu
F. Sevgi Hatipoğlu
MKMurat Karatas
Murat Karatas
NÖNazife Gamze Özer Özlü
Nazife Gamze Özer Özlü
LYLevent Yücetin
Levent Yücetin
ÖKÖzgül Karayurt
Özgül Karayurt
Solid Organ Nakli Tarihçesi Adam USLU, F. Sevgi HATİPOĞLU, Yaprak SARIGÖL ORDİN, Murat KARATAŞ Organ Naklinde Temel Kavramlar Nazife Gamze ÖZER ÖZLÜ, Yaprak SARIGÖL ORDİN Solid Organ Nakli İle İlgili Yasal Düzenlemelerve Türkiye Ulusal Koordinasyon Sistemi Levent YÜCETİN, Arzu Kader HARMANCI SEREN Solid Organ Naklinde Etik ve Hemşirenin Rolü Buket ÇELİK Solid Organ Naklinde Multidisipliner Bakım Yaklaşımı Can KARACA, Tuğçe ZEYREK Solid Organ Nakli Alıcısının Hazırlığı Aylin DURMAZ EDEER, Adile SAVSAR Solid Organ Nakli İmmünolojisi Gökhan AYGÜN, Pakize AYGÜN Solid Organ Nakli Farmakolojisi ve Hemşirelik Yönetimi Özge İŞERİ, Elif BARIŞ Solid Organ Naklinde Enfeksiyon Hastalıklarıve Hemşirelik Bakımı Sibel NARGİZ KOŞUCU, Arife ALTIN ÇETİN, Ayla GÜRSOY, Umay BALCI Böbrek Nakli ve Hemşirelik Bakımı Böbrek Nakli Cerrahi Süreci Hakan ÖZDEMİR, İbrahim BERBER Böbrek Nakli Öncesi ve Sonrası Hemşirelik Bakımı Serap ARICAN, Canan BAKAN Karaciğer Nakli ve Hemşirelik Bakımı Karaciğer Nakli Cerrahi Süreci Rasim FARAJOV, Murat KILIÇ Karaciğer Nakli Öncesi ve Sonrası Hemşirelik Bakımı Bilsev DEMİR, Nebile ÇUBUK Kalp Nakli ve Hemşirelik Bakımı Kalp Nakli Cerrahi Süreci Halit ER, Serap AYKUT AKA Kalp Nakli Öncesi ve Sonrası Hemşirelik Bakımı Fatma DEMİR KORKMAZ, Tuğba Nur ÖDEN Akciğer Nakli ve Hemşirelik Bakımı Akciğer Nakli Cerrahi Süreci Ali ÖZDİL, Gizem KEÇECİ ÖZGÜR Akciğer Nakli Öncesi ve Sonrası Hemşirelik Bakımı Eda Ayten KANKAYA Pankreas Nakli ve Hemşirelik Bakımı Deniz ŞANLI, Gülten SUCU DAĞ Solid Organ Nakli Sonrası Uzun Dönem Komplikasyonlar ve Hemşirelik Bakımı Bahar ASLAN DOĞAN, Sedef SELÇUK TOPBAŞ, Didem KANDEMİR Canlı Verici Bakımı Esma ÖZŞAKER, Rukiye İNAL, Ebru GÜLCAN Solid Organ Nakli Alıcısında Psikososyal Sorunlar ve Hemşirelik Bakımı Nilgün AKSOY, Büşra Nur TEMÜR Solid Organ Nakli Canlı Vericisinde Psikososyal Sorunlar ve Hemşirelik Bakımı Burcu ARKAN, Gülfer PEHLİVAN, Şirin DURMUŞ Solid Organ Nakli Alıcı ve Verici Eğitimi Büşra Selma SAHA, Nurşen ALTUĞ, Sinem ARAS Pediatrik Organ Nakilleri Öncesi ve Sonrası Hemşirelik Bakımı Rabiye GÜNEY, Duygu YILMAZ Yaşlılarda Organ Naklinde Öncesi ve Sonrası Hemşirelik Bakımı Hale TURHAN DAMAR Solid Organ Nakli Sonrası Cinsel Yaşam, Doğum Kontrol Yöntemleri, Gebelik ve Emzirme Özgül KARAYURT, Adile SAVSAR Solid Organ Transplantasyonu ile İlgili Kurum, Kuruluşlar ve Bilgi Kaynakları Yaprak SARIGÖL ORDİN

17 December 2025 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
TYTansu Yamazhan
Tansu Yamazhan
EZEsra Zerdali
Esra Zerdali
YÖYusuf Önlen
Yusuf Önlen
STSelma Tosun
Selma Tosun
ÖGÖzgür Günal
Özgür Günal
RGRahmet Güner
Rahmet Güner
Background/Aims: Selecting the initial antiviral regimen for chronic hepatitis B (CHB) requires balancing patients’ comorbidities and long-term safety. This study examines differences in patient and disease-related factors that guide clinicians to prescribe either ente cavir (ETV) or tenofovir disoproxil fumarate (TDF) as the initial treatment. Materials and Methods: The study included treatment-naïve CHB patients aged 18 or older who had been diagnosed for at least 1 year since 2010 and initiated on antiviral therapy. The data included variables such as age, gender, body mass index (BMI), comorbidities, liver disease activity, biopsy results, cirrhosis, hepatic steatosis, hepatitis B e-antigen status, hepatitis B virus DNA levels, triglycerides, cholesterol, renal function, and baseline bone mineral density (BMD), which were assessed by dual-energy x-ray absorptiometry (DEXA). Results: Among 2259 patients (61.6% male), 1270 patients (56.22%) received TDF, while 989 patients (43.78%) received ETV as firstline therapy. The TDF was more commonly prescribed to patients with a lower BMI (median

1 November 2025 in Journal of Clinical and Analytical Medicine
Verified
Journal Article
Closed access
UBUmay Balcı
Umay Balcı
ADAYLIN ERMAN DALOGLU
AYLIN ERMAN DALOGLU
ZOZahide Aşık Otman
Zahide Aşık Otman
HEHalil Er
Halil Er
ÖKÖzlem Koca
Özlem Koca
Aim Sexually transmitted infections (STIs) globally pose a significant public health concern, adversely impacting quality of life. This study assessed multiplex PCR test results using a commercial assay for detecting prevalent bacterial STI agents in urine samples. Methods A total of 1055 patients whose urine samples were sent to the Medical Microbiology Laboratory between May 2019 and December 2022 for PCR testing for detecting Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV) due to suspicion of STIs were included. Results Patients averaged 32.71 ± 10.72 years, with 58.9% females and 41.1% males. PCR positivity for CT, NG, MG and TV agents was detected in 177 (16.8%) of the patients. The top three pathogens detected were CT (46.9%), NG (24.3%) and MG (18.1%), respectively. PCR positivity was detected at a higher rate in male patients. The average age of patients with PCR positivity (28.94 ± 8.38) was lower than the average age of patients with PCR negativity (33.47 ± 10.98). The co-infection rate with two or three pathogens was determined as 9.6%. Conclusion Multiplex PCR tests for STIs offer significant advantages by concurrently testing multiple agents. Screening, particularly for young and at-risk male individuals, using multiplex PCR is crucial for early diagnosis, treatment, and transmission prevention.